← Leaderboards
Fernando Elijovich
University Of Texas Medical Br Galveston
$34,211
Attributed
$34,211
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$34,211 · 2
By mechanism
M01$34,211 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Jonathan B Ward$3,177,208
- Karl E Anderson$2,405,375
- Lee-Jane W Lu$7,395,875
- Samuel T. Kuna$10,369,696
- Sankar Mitra$15,620,345
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectAntihypertensive AgentsDrug Screening /EvaluationHuman Therapy EvaluationHypertensionAfrican AmericanEndothelinKallikreinsObesityPhenotypeRacial /Ethnic DifferenceReninSiblingsUrinalysisAlpha Adrenergic ReceptorBiomarkerBlood ChemistryDisease /Disorder ClassificationEssential HypertensionHispanic AmericansHormone Regulation /Control Mechanism
Grant awards (4)
Safety, tolerability &antihypertensive efficacy of multiple dose L-753$0
M01 · FY2002 · RR
Safety, tolerability &antihypertensive efficacy of multiple dose L-753$0
M01 · FY2001 · RR
CLASSIFICATION OF INTERM. PHENOTYPES IN SIBLINGS WITH ESSENTIAL HYPERTENSION$34,211
M01 · FY2000 · RR
Safety, tolerability &antihypertensive efficacy of multiple dose L-753$0
M01 · FY2000 · RR